Seattle Cancer Care Alliance (SCCA) is a cancer treatment and research center in Seattle, Washington. Established in 1998, this nonprofit provides clinical oncology care for patients treated at its three partner organizations: Fred Hutchinson Cancer Research Center, Seattle Children's and UW Medicine.[1] Together, these four institutions form the Fred Hutch/University of Washington Cancer Consortium.[1]
On April 1, 2022, Seattle Cancer Care Alliance and Fred Hutchinson Cancer Research Center merged to form Fred Hutchinson Cancer Center, a unified adult cancer research and care center that is clinically integrated with University of Washington (UW) Medicine and UW Medicine's cancer program.[2]
In 2015, the Puget Sound Business Journal reported that SCCA employed 1,200 people, and treated more than 7,000 patients from around the world.[4] That same year, SCCA researchers performed more than 200 clinical trials, investigating 48 different forms of cancer.[8] In 2017, SCCA treated more than 38,000 patients, deriving most of its revenue from outpatient care.[9] SCCA, along with its consortium partners, is the only NCI-designated comprehensive cancer center in Washington state.[9] These centers receive support from the National Cancer Institute, and must show expertise in research, patient care, and education.[10]
Nancy Davidson, MD, is the president and executive director of SCCA.[11] In January 2020, Aaron Crane was announced as executive vice president.[12]
Recognition
Since 2008, U.S. News & World Report has named SCCA among its nationally ranked cancer hospitals in the United States. In 2019–2020, SCCA was ranked fifteenth and was also noted as "High Performing" in two areas: colon cancer surgery and lung cancer surgery.[13]
In 2017, Becker's Hospital Review named SCCA one of the top 150 places to work in healthcare.[14] The Seattle Chamber of Commerce named SCCA 2017 Nonprofit of the Year, an award that acknowledges organizations for meaningful contributions to the local community.[15]
In 2019, the monthly magazine Seattle Met featured 78 doctors, physician assistants and nurse practitioners from SCCA on its "Top Doctors" list.[16] These health care providers are nominated by their peers based on a variety of factors, such as years of experience, competency and patient satisfaction.
History
2001: SCCA opened its first outpatient clinic at 1354 Aloha Street in the South Lake Union neighborhood of Seattle.[4][17]
2003: Olympic Medical Center in Sequim, Washington, became SCCA's first affiliate member.[19]
2006: SCCA opened the Fred Hutchinson Cancer Research Survivorship Center with a grant from the Lance Armstrong Foundation.[20]
2008: SCCA introduced the MammoVan, a mobile digital mammography service that travels to communities throughout the Seattle area offering breast cancer screenings.[21][22]
2009: SCCA opened an 80-suite residence, known as SCCA house, for patients traveling long distances to its facility for cancer treatment.[23][24]
2013: In partnership with ProCure Treatment centers, SCCA launched a proton therapy center, the only one of its kind in a seven-state region.[25][26][27]
2014: SCCA underwent a federal investigation after a staff member was discovered stealing oxycodone pills.[28] Subsequently, SCCA agreed to pay a $250,000 fine and institute new prescription drug protocols to prevent future fraud.[29]
2015: Rainier Storb, MD, received a $12.9 million grant to research new methods for improving the safety of stem-cell transplantation for people with congenital disorders.[30]
2016: SCCA opened the Prostate Cancer Genetics Clinic. The first of its kind in the United States, this clinic offers genetic testing, counseling, and consultations to help patients determine if they carry inherited genes that increase their risk of contracting various forms of prostate cancer.[31][32]
2016: The 9,000-square-foot Bezos Family Immunotherapy Clinic opened on the sixth floor of SCCA. The Seattle Times reported that the clinic was expected to increase the number of clinical trials available that test immunotherapy treatments.[33]
2017: SCCA opened a multispecialty clinic for patients with kidney cancer. One of the first of its kind in the United States, it allows patients to see a medical oncologist, urologist, and radiation oncologist in one appointment.[34]
2018: The National Institutes of Health awarded Fred Hutchinson Cancer Research Center a $10.24 million grant for Latina breast cancer research. SCCA's MammoVan will assist in testing whether specific interventions increase mammography screening rates for Latina women.[35]
2018: SCCA opened the Hematologic Malignancy Genetics Clinic, which provides genetic testing, counseling, and follow-up care for patients who may have an inherited risk of developing malignant blood disorders.[36]
2019: SCCA opened two community clinics in Poulsbo and Issaquah.[37][38]
2019: Washington State Governor Jay Inslee signed the Tobacco 21 Bill into law in a ceremony at Fred Hutchinson Cancer Research Center. The legislation makes it illegal to sell or give tobacco or vaping products to anyone under the age of 21. In attendance were SCCA doctors and leaders, including Nancy Davidson, MD, president and executive director of SCCA, and Keith Eaton, MD, PhD, clinical director of thoracic, head and neck cancer at SCCA.[39][40][41]
2020: SCCA Peninsula, a radiation therapy clinic in Poulsbo, Washington, expanded its on-site services to include the following: hematology and oncology consultation and management, infusion therapy as well as pharmacy and supportive care.[42]
Locations
Seattle Cancer Care Alliance has nine clinic locations:
South Lake Union: The main clinic provides outpatient oncology care for adult patients and pediatric services for children undergoing bone marrow transplantation.
Seattle Cancer Care Alliance Peninsula: Located in Poulsbo, Washington, this clinic provides radiation and medical oncology services.
Seattle Cancer Care Alliance Issaquah: Located in Issaquah, Washington, this clinic provides comprehensive cancer care, including medical oncology, infusion therapy, hematology, phlebotomy, nutrition and social work.
Seattle Children's: SCCA provides inpatient care for children at this location. Services include medical oncology, hematology, and surgical oncology.
SCCA at UW Medical Center: The Seattle Cancer Care Alliance Hospital located at UW Medical Center provides inpatient oncology care for adults.
SCCA at EvergreenHealth: Located in Kirkland, Washington, this clinic provides outpatient medical oncology and hematology services for adults at Halvorson Cancer Center.[43][44]
SCCA at UW Medicine's Northwest Hospital: This location provides outpatient oncology and hematology services.
SCCA Proton Therapy Center: Opened in 2013, the center is located on the UW Medicine Northwest Hospital & Medical Center campus. As of August 2018, it is one of 27 proton therapy centers in the United States.[45]
SCCA at Overlake Medical Center: Located in Bellevue, Washington, this clinic will provide hematology, medical oncology, and infusion services, starting in July 2020.[46][47]
Network members
SCCA's Network Program provides cancer diagnostic and treatment information to community-based physicians at oncology programs throughout five states: Alaska, Montana, Idaho, Hawaii, and Washington.[8][48][33] Members of the SCCA Network receive access to clinical trials, continuing education, consultations, and other resources.[48]
Related Research Articles
The Fred Hutchinson Cancer Center, formerly known as the Fred Hutchinson Cancer Research Center and also known as Fred Hutch or The Hutch, is a cancer research institute established in 1975 in Seattle, Washington.
In medicine, proton therapy, or proton radiotherapy, is a type of particle therapy that uses a beam of protons to irradiate diseased tissue, most often to treat cancer. The chief advantage of proton therapy over other types of external beam radiotherapy is that the dose of protons is deposited over a narrow range of depth; hence in minimal entry, exit, or scattered radiation dose to healthy nearby tissues.
Moffitt Cancer Center & Research Institute is a nonprofit cancer treatment and research center located in Tampa, Florida. Established in 1981 by the Florida Legislature, the hospital opened in October 1986 on the University of South Florida's campus. Moffitt is one of two National Cancer Institute-designated Comprehensive Cancer Centers based in Florida. In 2021, U.S. News & World Report ranked Moffitt Cancer Center as a top 30 cancer hospital in the United States.
Uppsala University Hospital in Uppsala, Sweden, is a teaching hospital for the Uppsala University Faculty of Medicine and the Nursing School. Uppsala University Hospital is owned and operated by the Uppsala County Council in cooperation with the university and serves, together with Enköping hospital in Enköping, as the primary hospitals for Uppsala County. It also fills the function of a tertiary referral hospital for the Uppsala/Örebro health care region and, for certain specialities, a tertiary referral hospital for the entire country of Sweden.
The University of Washington School of Medicine is the medical school of the University of Washington, a public research university in Seattle, Washington. According to U.S. News & World Report's 2022 Best Graduate School rankings, University of Washington School of Medicine ranked #1 in the nation for primary care education, and #7 for research.
Fast neutron therapy utilizes high energy neutrons typically between 50 and 70 MeV to treat cancer. Most fast neutron therapy beams are produced by reactors, cyclotrons (d+Be) and linear accelerators. Neutron therapy is currently available in Germany, Russia, South Africa and the United States. In the United States, one treatment center is operational, in Seattle, Washington. The Seattle center uses a cyclotron which produces a proton beam impinging upon a beryllium target.
The Society for Immunotherapy of Cancer (SITC), previously known as the International Society for Biological Therapy of Cancer (iSBTc), is a professional society of scientists, academicians, researchers, clinicians, government representatives, and industry leaders from around the world dedicated to improving outcomes in patients with cancer by advancing the science and application of cancer immunotherapy. Currently, SITC has more than 2,400 members, representing 22 medical specialties from 42 countries around the world, who are engaged in the research and treatment of cancer.
UW Medical Center – Northwest is a 281-bed hospital in Seattle, Washington. It was built in 1960 and became part of the UW Medicine system in 2010. Prior to the merger, a 1997 agreement had already made Northwest the home for a UW Medicine cardiac surgery program.
The University of Florida College of Medicine – Jacksonville is the largest of the three University of Florida Health Science Center Jacksonville colleges — medicine, nursing and pharmacy. The college's 16 clinical science departments house more than 440 faculty members and 380 residents and fellows. The college offers 34 accredited graduate medical education programs and 10 non-standard programs.
Uganda Cancer Institute (UCI) is a public, specialized, tertiary care medical facility owned by the Uganda Ministry of Health. It is designated as East Africa's Centre of Excellence in Oncology. In collaboration with Makerere University College of Health Sciences, UCI plans to start offering master's degrees, doctoral programs and post-doctoral fellowships in oncology care.
Gibbs Cancer Center & Research Institute is a cancer treatment and research facility in Upstate South Carolina. Gibbs Cancer Center is associated with the NCI Community Cancer Centers Program and the Medical University of South Carolina. Gibbs has several locations across the upstate of South Carolina, including Comprehensive Cancer Centers at both Spartanburg Medical Center and Pelham Medical Center. Additional infusion facilities are located in Gaffney, Union, Mary Black and North Grove.
Winship Cancer Institute of Emory University is a nonprofit cancer research and patient care center based in Atlanta, Georgia. Winship Cancer Institute is the only National Cancer Institute-designated Comprehensive Cancer Center in Georgia.
Dorothy "Dottie" Thomas was an American hematology researcher and administrator known for her work in developing bone marrow transplants. She and her husband, Edward Donnall Thomas, partnered to research leukemia and other blood disorders, and developed the technique for transplanting bone marrow. Her husband was awarded a Nobel Prize in Physiology or Medicine in 1990 due to his discoveries about cell and organ transplantation in the treatment of human diseases that he had completed along with Dorothy. This Nobel Prize was shared with Joseph Edward Murray, an American plastic surgeon.
Jackson Orem is a physician, medical oncologist and researcher in Uganda. He has served as the director of the Uganda Cancer Institute, since 2004.
David G. Maloney is an oncologist and researcher at Fred Hutchinson Cancer Research Center and the University of Washington who specializes in developing targeted immunotherapies for the treatment of blood cancers.
Nancy E. Davidson is the executive director and president of Seattle Cancer Care Alliance, senior vice president, director of clinical oncology at Fred Hutchinson Cancer Research Center and head of the Division of Medical Oncology at the University of Washington School of Medicine. She focuses her research on breast cancer treatments and the genes that are mutated in various forms of breast cancer. She was president of American Association for Cancer Research from 2015 to 2016 and president of American Society of Clinical Oncology from 2007 to 2008.
Victoria Walusansa-Abaliwano, is a Ugandan physician and oncologist, who works as the Deputy Director of the Uganda Cancer Institute (UCI), a cancer treatment and research institution, based in Kampala, Uganda and serving the countries of the African Great Lakes area.
Stephanie J. Lee is an American haematologist and physician scientist who is Professor and Associate Director at the Fred Hutchinson Cancer Research Center. Lee works to improve the lives of blood stem cell transplant and bone marrow patients by better understanding the chronic form of graft-versus-host disease. Lee is the former President of the American Society of Hematology.
Philip Greenberg is a professor of medicine, oncology, and immunology at the University of Washington and head of program in immunology at the Fred Hutchinson Cancer Research Center. His research is centered around T cell biology and therapeutic cell therapies. He is a co-founder of Juno Therapeutics.
Beverly Jo Torok-Storb was an American physician who was Professor of Clinical Research at the Fred Hutchinson Cancer Research Center. Her work considered the stem cells that generate blood and the microenvironment of bone marrow.
This page is based on this Wikipedia article Text is available under the CC BY-SA 4.0 license; additional terms may apply. Images, videos and audio are available under their respective licenses.
